Valeur202020212022202320242025Total du passif60.72 M301.33 M273.6 M478.39 M948.74 M881.88 MTotal des capitaux propres461.78 M408.82 M418.34 M287.16 M191.06 M503.42 MTotal du passif et des capitaux propres522.5 M710.15 M691.94 M765.55 M1.14 B1.39 BDette totale————393.18 M254.88 MDette nette————-185.09 M-437.94 M
Arrowhead Pharmaceuticals, Inc. - Common Stock
Arrowhead Pharmaceuticals, Inc. is a publicly traded biopharmaceutical company based in Pasadena, California. Arrowhead's products in development act through RNA interference mechanisms of action. The company focuses on treatments for hepatitis B, liver disease associated with alpha 1-antitrypsin deficiency and cardiovascular disease.